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Abstract
Background: Dry eye disease is a common debilitating ocular disease. Current diagnostic tests used in dry eye
disease are often neither sensitive nor reproducible, making it difficult to accurately diagnose and determine end
points for clinical trials, or evaluate the usefulness of different medications in the treatment of dry eye disease.
The recently developed fluorophotometer can objectively detect changes in the corneal epithelium by
quantitatively measuring its barrier function or permeability. The purpose of the study is to investigate the use of
corneal fluorescein penetration measured by the fluorophotometer as a diagnostic tool in the evaluation of dry
eye patients.
Methods: Dry eye patients (16 eyes), who presented with a chief complaint of ocular irritation corresponding
with dry eye, low Schirmer's one test (<10 mm after 5 minutes) and corneal fluorescein staining score of more
than two, were included in the study. Normal subjects (16 eyes), who came for refraction error evaluation, served
as controls. Institutional Review Board (IRB) approved consent was obtained before enrolling the subjects in the
study and all questions were answered while explaining the risks, benefits and alternatives. All Fluorophotometry
of the central corneal epithelium was done utilizing the Fluorotron Master (TradeMark). Each eye had a baseline
fluorescein scan performed, after which 50 l of 1% sodium fluorescein dye was instilled. Three minutes later, the
fluorescein was washed with 50 ml of normal saline. Fluorescein scans were then started immediately after
washing and were recorded at 10, 20, 40, and 60 minutes thereafter. The corneal peak values of fluorescein
concentration were recorded within the central cornea in both dry eyes and in controls.
Results: Ten minutes after fluorescein installition, patients with dry eye disease averaged a five-fold increase in
corneal tissue fluorescein concentration (mean = 375.26 ± 202.67 ng/ml) compared with that of normal subjects
(mean = 128.19 ± 85.84 ng/ml). Sixty minutes after dye installation, patients with dry eye disease still revealed
higher corneal tissue fluorescein concentration (mean = 112.87 ± 52.83 ng/ml) compared with that of controls
(mean = 40.64 ± 7.96 ng/ml), averaging a three-fold increase.
Conclusion: Patients with dry eye disease demonstrated an increased corneal permeability and a slower rate of
elimination to topically administered fluorescein when measured by the fluorophotometer. This suggests that
fluorophotometry may serve as a valuable quantitative and objective tool for the diagnosis of dry eye disease, and
in following patients' response to new treatment modalities. Fluorophotometry may serve as an objective non-
invasive tool for end-point analysis in clinical trials of new treatments for dry eye disease.
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Background
The fluorophotometer can detect clinical and subclinical
changes in the corneal epithelium by quantitatively meas-
uring the barrier function of the corneal epithelium [1-3].
Corneal epithelial cells are associated with tight junctions
that provide ocular protection by forming a resistant bar-
rier to the passage of hydrophilic substances, macromole-
cules, and pathogens[7]. Several investigators have
attempted to quantify this barrier function using fluoro-
photometry to measure the rate at which a topically
applied ophthalmic dye, fluorescein, penetrates the cor-
nea[8].
Fluorescein is a small, nontoxic, molecule that has the
property of emitting light energy of a longer wavelength
when stimulated by light of a shorter wavelength. The
excitation peak for fluorescein molecules is about 490 nm
(blue part of the spectrum) and represents the maximal
absorption of light energy by fluorescein. Fluorescein
molecules stimulated by this wavelength will be excited to
a higher energy level and will emit light of a longer wave-
length, which will be in the green portion of the spectrum
at about 530 nm[9]. The fluorophotometry device Fluor-
otron Master™, (Ocumetrics, Mountain View, CA, USA)
records the fluorescein concentration of different parts of
the eye including the cornea and vitreous.
Fluorophotometry may be useful clinically because an
increased corneal uptake of fluorescein reveals subtle
damage to the corneal epithelium. In humans, measure-
ments of the penetration of fluorescein across the corneal
epithelium could be of value in diagnosing or monitoring
dry eye disease. We were thus motivated in the present
study to evaluate the corneal barrier function in dry eye
patients to determine if fluorophotometry can be used as
a clinical diagnostic test for dry eye disease.
Methods
Design and setting
This was a pilot assessment designed to investigate the
reliability and consistency of the Fluorophotometer in
diagnosing dry eye disease. Data was collected from dry
eye patients to assess the permeability of fluorescein. This
study was carried out in the department of ophthalmol-
ogy at Mt. Sinai School of Medicine, New York. The
research was designed as a case-control study. All patients
examined received an informed consent, which was IRB
approved.
Subjects
IRB approved consent was obtained from all subjects
prior to the screening procedure at the clinical research
site. Informed consent was discussed with the patient, or
surrogate, in detail. Every topic was addressed separately.
All risks, benefits, and alternatives were discussed. Patient
was allowed to ask questions, and all questions were
answered. The assessment was made after that conversa-
tion, whether or not the patient understood the consent as
described above. Subjects were then informed whether
they were eligible to participate in the study after the
screening was done.
Dry eye patients (16 eyes), who presented with a chief
complaint of ocular irritation corresponding with dry eye,
low Schirmer's one test without anesthesia (<5 mm after
5 minutes) and corneal fluorescein staining score of more
than two, were included in the study. Normal subjects (16
eyes), who came for refraction error evaluation served as
controls.
Fluorophotometry of the central corneal epithelium was
done utilizing the Fluorotron Master™. Each eye had a
baseline fluorescein scan performed, after which 50 µl of
1% sodium fluorescein dye was installed. Three minutes
later, the fluorescein was washed with 50 ml of normal
saline for sixty seconds. Fluorescein scans were then
started immediately after washing and were recorded at
10, 20, 40, and 60 minutes thereafter. The corneal peak
values of fluorescein concentration were recorded within
the central cornea in both dry eyes and in controls. Each
patient underwent a comprehensive ophthalmic examina-
tion including a review of medical history, best-corrected
visual acuity, slit-lamp biomicroscopy, and dilated fundo-
scopic examination. Patients were excluded if they had a
history of laser or ocular surgeries, and if they anticipate
the use of any topical medication during the study period.
Patients (16 eyes), who presented with a chief complaint
of ocular irritation corresponding with dry eye, low
Schirmer's one test (<10 mm after 5 minutes) and corneal
fluorescein staining score of more than two, were
included in the study.
After installation of fluorescein, the ocular surface was
examined microscopically to evaluate the intensities of
corneal staining (degree 0–3) and conjunctival staining
(both nasally and temporally; degree 0–3). Fluorescein
staining was scored as 0 (0), 1 (1–3), 2 (4–6) or 3 (>7).
Those who had no symptoms of dry eyes and no other
ocular problems other than refractive error served as con-
trols (16 eyes).
Demographics
Fluorophotometry was measured in 16 patients, which
were classified as normal or dry eye patients according to
their presenting primary ocular symptoms, their
schirmer's test result and their corneal fluorescein staining
score. A total of 32 eyes were analyzed. The mean age (±
SD) of the dry eye patients and the controls was 47.50 (+
17.86) and 37.17 (+13.49) years respectively. Among ourBMC Ophthalmology 2006, 6:20 http://www.biomedcentral.com/1471-2415/6/20
Page 3 of 7
(page number not for citation purposes)
patients, 9 were Caucasian, 3 were Asian, and 4 were of
other ethnicity (Table 1).
Procedure
Fluorophotometry
Fluorophotometry of the central corneal epithelium was
performed with the Fluorotron Master™ (Ocumetrics,
Mountain View, CA) using the standard excitation and
emission filters and the corresponding scanning software.
This machine records the fluorescein concentration of dif-
ferent parts of the eye ranging from behind the crystalline
lens to the space outside the cornea. Before any fluores-
cein was installed, a baseline scan, measuring each eye's
intrinsic fluorescence, was performed using the Fluoro-
tron Master. 50 µl of 1% sodium fluorescein dye (in the
form of an eye drop) was then placed onto the tear film.
After waiting for three minutes, the fluorescein was
washed with 50 c.c. of normal saline. Fluorescein scans
were recorded at 10, 20, 40, and 60 minutes after washing.
The corneal peak values of fluorescein concentration were
noted for each exam.
Data analysis
From the data obtained, graphs were created to display the
fluorescein concentration (ng/ml) from behind the crys-
talline lens to the space outside the cornea for each time
period scans (Figure 1). The corneal peak concentration
values were recorded for analysis. The elimination rate of
fluorescein from the eye was calculated by calculating the
change in corneal fluorescein concentration over time.
Statistical significance was determined utilizing the stu-
dent t-test.
Results
Ten minutes after fluorescein installation, patients with
dry eye disease averaged a five-fold increase in corneal tis-
sue fluorescein concentration (mean = 375.26 + 202.67
ng/ml) compared with that of normal subjects (mean =
128.19 + 85.84 ng/ml). Sixty minutes after dye installa-
tion, patients with dry eye disease still revealed higher cor-
neal tissue fluorescein concentration (mean = 112.87 +
52.83 ng/ml) compared with that of controls (mean =
40.64 + 7.96 ng/ml), averaging a three-fold increase. The
increase in corneal fluorescein concentration in dry eye
patients is due to a defect in the corneal epithelial barrier
function. Therefore, the stain tends to pool within the cor-
neal epithelial layers for longer periods in patients with
dry eye disease.
The baseline scans of the dry eye patient group (21.70 +
2.60 ng/ml) and control group (22.42 + 2.56 ng/ml) did
not reveal a statistical difference. For each of the timed
scans recorded after washing, there was a statistically sig-
nificant difference (p < 0.05) in corneal fluorescein con-
centrations between the dry eye disease groups versus the
control group (Table 2). The dry eye disease group had a
higher corneal peak fluorescein concentration compared
to the control group (Figure 2). A ratio of the corneal flu-
orescein concentration at 60 minutes to the baseline fluo-
rescence was also used for comparison (Table 2). The dry
eye disease group had a higher ratio than the control
group, and the difference was statistically significant (p =
0.000277).
We also estimated the elimination rate of fluorescein from
the cornea between each of the scans. The elimination rate
of fluorescein from the eye was statistically different when
comparing the two groups (Table 3). It appeared that the
rate of fluorescein elimination was greater in the dry eye
group verse that of the control. Since the tear turnover rate
is different between dry eye and normal controls, the
elimination rate is of little significance.
Discussion
Dry eye disease is a common source of great discomfort
affecting people of all ages. It can seriously diminish a
patient's quality of life, putting its greatest burden on the
elderly population [11,12]. Its management can be a frus-
Table 1: Patient Demographics. Fluorophotometry was measured in 16 patients, which were classified as normal or dry eye patients 
according to their presenting primary ocular symptoms, their schirmer's test result and their corneal Fluorescein staining score.
Number of Subjects in Our Study 16
Gender:
Male 4
Female 12
Mean Age ± SD in Controls (years): 37.17 ± 13.49
Mean Age ± SD in Dry Eye Patients (years): 47.50 ± 17.86
Race:
Caucasian 9
Asian 3
Others 4
Diagnosis:
Normal Patients 8
Dry Eye Disease Patients 8BMC Ophthalmology 2006, 6:20 http://www.biomedcentral.com/1471-2415/6/20
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trating experience for patients and their eye care providers
particularly because most clinicians still rely on tradi-
tional tests, such as tear breakup time, Schirmer, and ocu-
lar surface dye staining for diagnosis and follow up of dry
eye disease. Many newer diagnostic tools aiming to
improve sensitivity and specificity over conventional test-
ing have emerged over the last several years.
These techniques include tear film osmolarity, scanning
confocal microscopy, infrared thermography, fluorogenic
substrate techniques and tear fluid protein immunoassays
[4,5]. Although these techniques have not gained wide-
spread clinical acceptance, the preliminary results indicate
that tear composition and clearance appear to have a
stronger correlation with the severity of ocular surface irri-
tation symptoms in comparison to the Schirmer test,
which evaluates tear production alone [11]. However
these tests are difficult to utilize and are rarely used clini-
cally and are in no way performed in clinical trials. Several
studies report that the anterior fluorophotometer quanti-
tatively measures the degree of breakdown of corneal epi-
thelial barrier function [15-19]. Fluorophotometry may
possibly be a new objective tool for diagnosing dry eye
disease that is easy to operate.
Our results showed no statistical difference between the
baselines scans. This was expected since the inherent fluo-
rescence of the eye should theoretically be similar in both
groups. However, the dry eye disease group had a signifi-
cantly higher corneal peak fluorescein concentration than
the control group at all scan times, suggesting an uptake
of fluorescein in the superficial punctuate keratopathy.
Based on this information we can measure the corneal flu-
orescence intensity and convert into fluorescein concen-
tration. In aqueous-tear deficient dry eye patients
fluorescein uptakes showed increased absorption of fluo-
rescein from the tear film through the corneal epithelium
i.e. greater severity in superficial punctuate keratopathy in
dry eye patients.
There was a large standard deviation with a significant
overlap in the levels of corneal fluorescein concentration
and rate of fluorescein elimination in the early scans (at
10 and 20 min) between the dry eye patients and the con-
trols. As the time from the original administration of the
dye to the scan time increased, the amount of overlap
between the data of the two groups decreased, thus
improving the accuracy in distinguishing dry eye patients
from the controls, and increasing the reliability of fluoro-
photometry as a diagnostic tool.
One possible explanation for the observed early variances
in our data is the variation in the severity of dry eye dis-
ease in our patient group. Another is the different
response of patients' eyes to fluorescein such as excessive
tearing, blinking and eye squeezing. An additional reason
is that the Fluorotron Master may have measured residual
fluorescein in the tear film.
The early results are confounded by the high concentra-
tion in the tear film and the Fluorotron Master is unable
to distinguish the tear film from the cornea, this would
affect the measurements of peak corneal fluorescein con-
centration [12,13]. Previous studies have shown difficul-
ties with calculating permeability where either corneal
thickness [14] or tear film thickness [13] had to be
Table 3: Elimination Rate of Fluorescein (ng/ml/min). Elimination Rate of Fluorescein (ng/ml/min) was recorded at various intervals. 
The elimination rate of fluorescein from the eye was statistically different when comparing the two groups.
10–20 min rate 20–40 min rate 40–60 min rate 10–40 min rate
DED Mean 17.27 4.18 0.30 8.54
St Dev 11.71 4.08 0.34 5.41
Normal Mean 6.20 1.02 0.26 2.75
St Dev 7.28 1.21 0.40 2.87
P value 0.008062675 0.017622827 0.7451916 0.002823332
* DED = Dry Eye Disease
Table 2: Corneal Peak Fluorescence (ng/ml) at different times. Corneal Peak Fluorescence (ng/ml) was measured at different times. A 
ratio of the corneal fluorescein concentration at 60 minutes to the baseline fluorescence was also used for comparison.
Baseline 10 minutes 20 minutes 40 minutes 60 minutes 60/baseline
DED Mean 22.42 375.26 202.57 118.95 112.87 5.04
St Dev 2.56 202.67 117.78 52.47 52.83 2.23
Normal Mean 21.70 128.19 66.23 45.80 40.64 1.92
St Dev 2.60 85.84 26.30 11.52 7.96 0.30
P value 0.437675 0.00088774 0.001278239 0.00027737 0.0003374 0.000276759
* DED = Dry Eye DiseaseBMC Ophthalmology 2006, 6:20 http://www.biomedcentral.com/1471-2415/6/20
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assumed. Therefore, utilizing measurements at 60 min-
utes post fluorescein placement helped to more easily dis-
tinguish the two groups.
In conclusion, our data suggests that fluorophotometry
may serve as a valuable quantitative and objective tool for
the diagnosis of dry eye disease. In addition, peak corneal
fluorescein concentration may generate a new classifica-
tion system that would quantify mild, moderate and
severe dry eye disease. Fluorophotometry may offer an
objective non-invasive tool for endpoint analysis in clini-
cal trials of new treatments for dry eye disease. Future eval-
uation of fluorophotometry and corneal permeability is
warranted.
Conclusion
Patients with dry eye disease demonstrated an increased
corneal permeability and a slower rate of elimination to
topically administered fluorescein when measured by the
fluorophotometer. This suggests that fluorophotometry
may serve as a valuable quantitative and objective tool for
the diagnosis of dry eye disease, and in following patients'
response to new treatment modalities. Fluorophotometry
may serve as an objective non-invasive tool for end-point
analysis in clinical trials of new treatments for dry eye dis-
ease.
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Patient Demographics: Subject view of the Fluotron results at baseline scan. The initial peaks indicate fluorescein concentration 
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Corneal Peak Fluorescence: Demonstrates the comparison of Mean Fluorescein peak concentrations between dry eye patients  and controls Figure 2
Corneal Peak Fluorescence: Demonstrates the comparison of Mean Fluorescein peak concentrations between dry eye patients 
and controls.
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